Lack of correlation between immunohistochemical expression of E2F-1, thymidylate synthase expression and clinical response to5-fluorouracil in advanced colorectal cancer-Reference-Cited by-同舟云学术

Lack of correlation between immunohistochemical expression of E2F-1, thymidylate synthase expression and clinical response to5-fluorouracil in advanced colorectal cancer

Published:2004-01 Issue:1 Volume:15 Page:55-58
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Belvedere O.,Puglisi F.,Di Loreto C.,Cataldi P.,Guglielmi A.,Aschele C.,Sobrero A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/15/1/55/332880/mdh018.pdf

Reference14 articles.

1. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors;Johnston;Cancer Res,1995

2. Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin;Leichman;J Clin Oncol,1997

3. Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy;Aschele;J Clin Oncol,1999

4. Thymidylate synthase expression: an independent prognostic factor for local recurrence, distant metastasis, disease-free and overall survival in rectal cancer;Edler;Clin Cancer Res,2000

5. Cellular targets for activation by the E2F-1 transcription factor include DNA synthesis and G1/S regulatory genes;DeGregori;Mol Cell Biol,1995

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. E2F1/TS Immunophenotype and Survival of Patients with Colorectal Cancer Treated with 5FU-Based Adjuvant Therapy;Pathology & Oncology Research;2016-01-29

2. Downregulation of thymidylate synthase with arsenic trioxide in lung adenocarcinoma;International Journal of Oncology;2014-04-02

3. Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years;World Journal of Gastroenterology;2014

4. Glycogen synthase kinase 3β inhibitor (2′Z,3′E)-6-bromo-indirubin-3′-oxime enhances drug resistance to 5-fluorouracil chemotherapy in colon cancer cells;Chinese Journal of Cancer Research;2012-05-22

5. TS gene polymorphisms are not good markers of response to 5-FU therapy in stage III colon cancer patients;Cellular Oncology;2011-06-01